Recapitulating the Cancer Microenvironment Using Bioprinting Technology for Precision Medicine

The complex and heterogenous nature of cancer contributes to the development of cancer cell drug resistance. The construction of the cancer microenvironment, including the cell–cell interactions and extracellular matrix (ECM), plays a significant role in the development of drug resistance. Tradition...

Full description

Bibliographic Details
Main Authors: Jisoo Kim, Jinah Jang, Dong-Woo Cho
Format: Article
Language:English
Published: MDPI AG 2021-09-01
Series:Micromachines
Subjects:
Online Access:https://www.mdpi.com/2072-666X/12/9/1122
_version_ 1797518135426809856
author Jisoo Kim
Jinah Jang
Dong-Woo Cho
author_facet Jisoo Kim
Jinah Jang
Dong-Woo Cho
author_sort Jisoo Kim
collection DOAJ
description The complex and heterogenous nature of cancer contributes to the development of cancer cell drug resistance. The construction of the cancer microenvironment, including the cell–cell interactions and extracellular matrix (ECM), plays a significant role in the development of drug resistance. Traditional animal models used in drug discovery studies have been associated with feasibility issues that limit the recapitulation of human functions; thus, in vitro models have been developed to reconstruct the human cancer system. However, conventional two-dimensional and three-dimensional (3D) in vitro cancer models are limited in their ability to emulate complex cancer microenvironments. Advances in technologies, including bioprinting and cancer microenvironment reconstruction, have demonstrated the potential to overcome some of the limitations of conventional models. This study reviews some representative bioprinted in vitro models used in cancer research, particularly fabrication strategies for modeling and consideration of essential factors needed for the reconstruction of the cancer microenvironment. In addition, we highlight recent studies that applied such models, including application in precision medicine using advanced bioprinting technologies to fabricate biomimetic cancer models. Furthermore, we discuss current challenges in 3D bioprinting and suggest possible strategies to construct in vitro models that better mimic the pathophysiology of the cancer microenvironment for application in clinical settings.
first_indexed 2024-03-10T07:25:54Z
format Article
id doaj.art-3a5c0617631a467e874e74bb5075f04c
institution Directory Open Access Journal
issn 2072-666X
language English
last_indexed 2024-03-10T07:25:54Z
publishDate 2021-09-01
publisher MDPI AG
record_format Article
series Micromachines
spelling doaj.art-3a5c0617631a467e874e74bb5075f04c2023-11-22T14:16:55ZengMDPI AGMicromachines2072-666X2021-09-01129112210.3390/mi12091122Recapitulating the Cancer Microenvironment Using Bioprinting Technology for Precision MedicineJisoo Kim0Jinah Jang1Dong-Woo Cho2School of Interdisciplinary Bioscience and Bioengineering, Pohang University of Science and Technology (POSTECH), Pohang 37673, KoreaSchool of Interdisciplinary Bioscience and Bioengineering, Pohang University of Science and Technology (POSTECH), Pohang 37673, KoreaSchool of Interdisciplinary Bioscience and Bioengineering, Pohang University of Science and Technology (POSTECH), Pohang 37673, KoreaThe complex and heterogenous nature of cancer contributes to the development of cancer cell drug resistance. The construction of the cancer microenvironment, including the cell–cell interactions and extracellular matrix (ECM), plays a significant role in the development of drug resistance. Traditional animal models used in drug discovery studies have been associated with feasibility issues that limit the recapitulation of human functions; thus, in vitro models have been developed to reconstruct the human cancer system. However, conventional two-dimensional and three-dimensional (3D) in vitro cancer models are limited in their ability to emulate complex cancer microenvironments. Advances in technologies, including bioprinting and cancer microenvironment reconstruction, have demonstrated the potential to overcome some of the limitations of conventional models. This study reviews some representative bioprinted in vitro models used in cancer research, particularly fabrication strategies for modeling and consideration of essential factors needed for the reconstruction of the cancer microenvironment. In addition, we highlight recent studies that applied such models, including application in precision medicine using advanced bioprinting technologies to fabricate biomimetic cancer models. Furthermore, we discuss current challenges in 3D bioprinting and suggest possible strategies to construct in vitro models that better mimic the pathophysiology of the cancer microenvironment for application in clinical settings.https://www.mdpi.com/2072-666X/12/9/1122cancer biologycancer modeltissue engineeringbiofabricationcancer microenvironment
spellingShingle Jisoo Kim
Jinah Jang
Dong-Woo Cho
Recapitulating the Cancer Microenvironment Using Bioprinting Technology for Precision Medicine
Micromachines
cancer biology
cancer model
tissue engineering
biofabrication
cancer microenvironment
title Recapitulating the Cancer Microenvironment Using Bioprinting Technology for Precision Medicine
title_full Recapitulating the Cancer Microenvironment Using Bioprinting Technology for Precision Medicine
title_fullStr Recapitulating the Cancer Microenvironment Using Bioprinting Technology for Precision Medicine
title_full_unstemmed Recapitulating the Cancer Microenvironment Using Bioprinting Technology for Precision Medicine
title_short Recapitulating the Cancer Microenvironment Using Bioprinting Technology for Precision Medicine
title_sort recapitulating the cancer microenvironment using bioprinting technology for precision medicine
topic cancer biology
cancer model
tissue engineering
biofabrication
cancer microenvironment
url https://www.mdpi.com/2072-666X/12/9/1122
work_keys_str_mv AT jisookim recapitulatingthecancermicroenvironmentusingbioprintingtechnologyforprecisionmedicine
AT jinahjang recapitulatingthecancermicroenvironmentusingbioprintingtechnologyforprecisionmedicine
AT dongwoocho recapitulatingthecancermicroenvironmentusingbioprintingtechnologyforprecisionmedicine